Sign in
Active, not recruitingNo phase

Development of CELIAC-Q KIDS: A Patient-Reported Outcome Measure for Pediatric Celiac Disease

Key facts

Who runs it
McMaster University
Where
Canada2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
100 people, planned
Started
26 Oct 2020
Expected to end
31 Dec 2026
Type of study
Observational, 3 groups
Treatments tested
  • Interview and scale development
Record updated
4 November 2022

Who can take part

Age
4 years to 17 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patients diagnosed with celiac disease
  • Pediatric patients (18 years and younger)
  • Ability to understand and communicate in the English language

Who cannot take part

  • Patients who do not have celiac disease
  • Non-pediatric patients (over 18)
  • Unable to understand and communicate in the English language

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

A multicentre, prospective observational study to develop the CELIAC-Q KIDS patient reported outcome measure for children and adolescents with celiac disease. The CELIAC- Q KIDS will contain a comprehensive set of independently functioning scales designed to measure outcomes that matter to children with celiac disease, as well as scales to measure patients experience with the gluten-free diet.

The 3 groups in the trial

  • Pediatric Patients

    Pediatric patients with celiac disease.

    Treatment: Interview and scale development

  • Caregivers and parents

    Caregivers and parents of pediatric patients with celiac disease

    Treatment: Interview and scale development

  • Experts

    Group of experts in pediatric celiac disease to provide feedback on scale development.

    Treatment: Interview and scale development

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Phase 1 Protocol to Develop a Patient-reported Outcome Measure for Children and Adolescents With Celiac Disease: CELIAC-Q KIDS
Record updated
4 November 2022